Hassan Khalid

463 total citations
12 papers, 293 citations indexed

About

Hassan Khalid is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Hassan Khalid has authored 12 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Hassan Khalid's work include Natural product bioactivities and synthesis (3 papers), Natural Antidiabetic Agents Studies (3 papers) and Phytochemistry and Bioactive Compounds (2 papers). Hassan Khalid is often cited by papers focused on Natural product bioactivities and synthesis (3 papers), Natural Antidiabetic Agents Studies (3 papers) and Phytochemistry and Bioactive Compounds (2 papers). Hassan Khalid collaborates with scholars based in Sudan, Germany and Japan. Hassan Khalid's co-authors include Thomas Efferth, Mohamed E.M. Saeed, Onat Kadioglu, Yoshikazu Sugimoto, Irmgard Merfort, Stefan Jacob, Janine Naß, Eckhard Thines, Victor Kuete and Henry Johannes Greten and has published in prestigious journals such as Biomedicine & Pharmacotherapy, The Journal of Nutritional Biochemistry and Phytomedicine.

In The Last Decade

Hassan Khalid

11 papers receiving 288 citations

Peers

Countries citing papers authored by Hassan Khalid

Since Specialization

Citations

This map shows the geographic impact of Hassan Khalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassan Khalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassan Khalid more than expected).

Fields of papers citing papers by Hassan Khalid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassan Khalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassan Khalid. The network helps show where Hassan Khalid may publish in the future.

Co-authorship network of co-authors of Hassan Khalid

This figure shows the co-authorship network connecting the top 25 collaborators of Hassan Khalid. A scholar is included among the top collaborators of Hassan Khalid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hassan Khalid. Hassan Khalid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Atrial fibrillation in the emergency department: Predictors of admission and discharge—A nationwide analysis 2025 ·Heart Rhythm O2 ·(unknown), (unknown), Ishan Garg, Hassan Khalid, (unknown), (unknown), Karthik Gangu, (unknown), (unknown), Abu Baker Sheikh	0
2	Ameliorative activity of Adansonia digitata fruit on high sugar/high fat diet-simulated Metabolic Syndrome model in male Wistar rats 2020 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), (unknown), (unknown), Hassan Khalid	16
3	Toxic Effect of Gardenia ternifolia Fruit on Rats 2018 ·European Journal of Medicinal Plants ·(unknown), Hassan Khalid, (unknown), (unknown)	4
4	Toxicity of Kigelia africana Fruit in Rats 2018 ·Advances in Research ·(unknown), (unknown), Hassan Khalid, (unknown)	12
5	Evaluating ancient Egyptian prescriptions today: Anti-inflammatory activity of Ziziphus spina-christi 2016 ·Phytomedicine ·Onat Kadioglu, Stefan Jacob, (unknown), Janine Naß, Mohamed E.M. Saeed, Hassan Khalid, Irmgard Merfort, Eckhard Thines, (unknown), Thomas Efferth	71
6	A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin–docetaxel with or without trastuzumab in locally advanced breast cancer 2015 ·Cancer Chemotherapy and Pharmacology ·Taher Al‐Tweigeri, Adher Alsayed, (unknown), (unknown), (unknown), (unknown), Omalkhair Abulkhair, (unknown), Hassan Khalid, Dahish Ajarim	14
7	In vitro Antitheilerial Activity of Paluther (Artemether 80) Against Theileria lestoquardi 2015 ·British Biotechnology Journal ·(unknown), (unknown), Hassan Khalid, (unknown), (unknown), (unknown)	1
8	Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking 2015 ·Journal for ImmunoTherapy of Cancer ·Mohamed E.M. Saeed, Thomas Efferth, Onat Kadioglu, Hassan Khalid, Yoshikazu Sugimoto	25
9	Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells 2014 ·Phytomedicine ·Victor Kuete, Mohamed E.M. Saeed, Onat Kadioglu, (unknown), Hassan Khalid, Henry Johannes Greten, Thomas Efferth	20
10	Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking 2014 ·The Journal of Nutritional Biochemistry ·Mohamed E.M. Saeed, Onat Kadioglu, Hassan Khalid, Yoshikazu Sugimoto, Thomas Efferth	84
11	The lignan, (−)-sesamin reveals cytotoxicity toward cancer cells: Pharmacogenomic determination of genes associated with sensitivity or resistance 2014 ·Phytomedicine ·Mohamed E.M. Saeed, Hassan Khalid, Yoshikazu Sugimoto, Thomas Efferth	23
12	Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking 2014 ·Phytomedicine ·Mohamed E.M. Saeed, Victor Kuete, Onat Kadioglu, (unknown), Hassan Khalid, Henry Johannes Greten, Thomas Efferth	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact